(Alliance News) - Stocks were called to open flat in London, with market attention on a raft of corporate earnings, as well as a eurozone inflation reading at 1000 GMT. Read More
(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration's advisory committee voted to support its respiratory syncytial virus vaccine candidate for older adults. Read More
(Alliance News) - Stock prices in London closed mixed on Thursday, with blue-chips ending in the red on renewed concerns of higher rates in the US, as well as a host of stocks going ex-dividend. Read More
(Alliance News) - GSK PLC on Thursday said that ViiV Healthcare has found that its injectable Cabenuva is as effective as the daily oral Biktarvy in treating HIV-1. Read More
(Alliance News) - ViiV Healthcare on Wednesday said it received marketing authorisation from the European Commission for Triumeq PD, a treament for children living with HIV Read More
(Alliance News) - GSK PLC on Thursday said a New England Journal of Medicine publication announced positive phase III trial results for its respiratory syncytial virus vaccine candidate for older adults. Read More
(Alliance News) - GSK PLC on Friday said its drug Jemperli won a regular approval for a form of endometrial cancer and is set to be evaluated for a form of advanced rectal cancer in the US. Read More
(Alliance News) - GSK PLC on Thursday said its Jesduvroq drug has been approved by the US Food & Drug Administration for anaemia of chronic kidney disease in adults on dialysis. Read More
(Alliance News) - Stock prices in London opened higher on Wednesday, as investors expect to see the US central bank continue to slow the pace of its interest rate hikes. Read More
(Alliance News) - GSK PLC on Wednesday reported a growth in profit and revenue for 2022 as it looks towards a possible spate of drug approvals for 2023. Read More
(Alliance News) - Stocks in London were set to open higher on Wednesday, following positive leads from Wall Street and Asia, as investors anxiously look ahead to a trio of interest rate decisions this week. Read More
(Alliance News) - Haleon PLC on Tuesday said it will add Pfizer Inc Chief Financial Officer David Denton to its board of directors from March 1. Read More
IP Group PLC - Oxford, England-based intellectual property commercialisation company - Appoints Anita Kidgell as an independent non-executive director, effective from Wednesday. Kidgell is currently head of Corporate Strategy at GSK PLC. GSK is a London-based multinational pharmaceutical and biotechnology company. Says Kidgell will bring a combination of a scientific background together with strategic and communication experience in a listed company. Read More